123 related articles for article (PubMed ID: 10319410)
1. Immunosuppressive effects of the heat shock protein 90-binding antibiotic geldanamycin.
Sugita T; Tanaka S; Murakami T; Miyoshi H; Ohnuki T
Biochem Mol Biol Int; 1999 Apr; 47(4):587-95. PubMed ID: 10319410
[TBL] [Abstract][Full Text] [Related]
2. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase.
Stancato LF; Silverstein AM; Owens-Grillo JK; Chow YH; Jove R; Pratt WB
J Biol Chem; 1997 Feb; 272(7):4013-20. PubMed ID: 9020108
[TBL] [Abstract][Full Text] [Related]
3. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
4. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines.
Park JW; Yeh MW; Wong MG; Lobo M; Hyun WC; Duh QY; Clark OH
J Clin Endocrinol Metab; 2003 Jul; 88(7):3346-53. PubMed ID: 12843186
[TBL] [Abstract][Full Text] [Related]
5. Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.
Ochel HJ; Eichhorn K; Gademann G
Cell Stress Chaperones; 2001 Apr; 6(2):105-12. PubMed ID: 11599571
[No Abstract] [Full Text] [Related]
6. The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling.
Chakravortty D; Kato Y; Sugiyama T; Koide N; Mu MM; Yoshida T; Yokochi T
J Immunol; 2001 Feb; 166(3):2011-7. PubMed ID: 11160250
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins.
Shimamura T; Lowell AM; Engelman JA; Shapiro GI
Cancer Res; 2005 Jul; 65(14):6401-8. PubMed ID: 16024644
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin.
Yang J; Yang JM; Iannone M; Shih WJ; Lin Y; Hait WN
Cancer Res; 2001 May; 61(10):4010-6. PubMed ID: 11358819
[TBL] [Abstract][Full Text] [Related]
9. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
Schulte TW; Neckers LM
Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
[TBL] [Abstract][Full Text] [Related]
10. Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.
Neckers L; Schulte TW; Mimnaugh E
Invest New Drugs; 1999; 17(4):361-73. PubMed ID: 10759403
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of the Hsp90 inhibitor Geldanamycin: induction of apoptosis in PC12, and differentiation in N2A cells.
López-Maderuelo MD; Fernández-Renart M; Moratilla C; Renart J
FEBS Lett; 2001 Feb; 490(1-2):23-7. PubMed ID: 11172804
[TBL] [Abstract][Full Text] [Related]
12. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin.
Ma Y; Lakshmikanthan V; Lewis RW; Kumar MV
Mol Cancer Ther; 2006 Jan; 5(1):170-8. PubMed ID: 16432176
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.
Schulte TW; Akinaga S; Soga S; Sullivan W; Stensgard B; Toft D; Neckers LM
Cell Stress Chaperones; 1998 Jun; 3(2):100-8. PubMed ID: 9672245
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
Yun BG; Matts RL
Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741
[TBL] [Abstract][Full Text] [Related]
16. The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin.
Segnitz B; Gehring U
J Biol Chem; 1997 Jul; 272(30):18694-701. PubMed ID: 9228040
[TBL] [Abstract][Full Text] [Related]
17. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.
Grammatikakis N; Lin JH; Grammatikakis A; Tsichlis PN; Cochran BH
Mol Cell Biol; 1999 Mar; 19(3):1661-72. PubMed ID: 10022854
[TBL] [Abstract][Full Text] [Related]
18. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents.
Miyata Y
Curr Pharm Des; 2005; 11(9):1131-8. PubMed ID: 15853661
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-induced phosphorylation of ERK1/2 in explants of the mouse cerebral cortex: the roles of heat shock protein 90 (Hsp90) and MEK2.
Sétáló G; Singh M; Guan X; Toran-Allerand CD
J Neurobiol; 2002 Jan; 50(1):1-12. PubMed ID: 11748628
[TBL] [Abstract][Full Text] [Related]
20. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
